Biotech startup Allozymes closes $15m Series A co-led by Seventure, Xora Innovation

Biotech startup Allozymes closes $15m Series A co-led by Seventure, Xora Innovation

Photo: Allozymes's LinkedIn page

Singapore-headquartered biotech startup Allozymes, which specialises in enzyme discovery and engineering, on Tuesday announced the close of a $15-million Series A round co-led by Seventure Partners and Xora Innovation.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter